US Bancorp’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-780
| Closed | -$169K | – | 4142 |
|
|
2021
Q1 | $169K | Sell |
780
-15,750
| -95% | -$2.96M | ﹤0.01% | 2000 |
|
|
2020
Q4 | $1.91M | Buy |
16,530
+7,003
| +74% | +$785K | ﹤0.01% | 835 |
|
|
2020
Q3 | $927K | Sell |
9,527
-33
| -0.3% | -$3.8K | ﹤0.01% | 1034 |
|
|
2020
Q2 | $1.17M | Hold |
9,560
| – | – | ﹤0.01% | 902 |
|
|
2020
Q1 | $837K | Sell |
9,560
-2,150
| -18% | -$228K | ﹤0.01% | 979 |
|
|
2019
Q4 | $1.22M | Sell |
11,710
-82
| -0.7% | -$9.2K | ﹤0.01% | 969 |
|
|
2019
Q3 | $1.36M | Sell |
11,792
-66
| -0.6% | -$10K | ﹤0.01% | 917 |
|
|
2019
Q2 | $2.04M | Buy |
11,858
+175
| +1% | +$30.3K | 0.01% | 771 |
|
|
2019
Q1 | $1.97M | Buy |
11,683
+75
| +0.6% | +$11.2K | 0.01% | 780 |
|
|
2018
Q4 | $1.13M | Buy |
11,608
+208
| +2% | +$27.3K | ﹤0.01% | 952 |
|
|
2018
Q3 | $1.97M | Buy |
11,400
+200
| +2% | +$28.8K | 0.01% | 817 |
|
|
2018
Q2 | $1.56M | Sell |
11,200
-475
| -4% | -$67.5K | ﹤0.01% | 909 |
|
|
2018
Q1 | $1.31M | Sell |
11,675
-298
| -2% | -$37.5K | ﹤0.01% | 963 |
|
|
2017
Q4 | $1.58M | Sell |
11,973
-50
| -0.4% | -$5.88K | ﹤0.01% | 888 |
|
|
2017
Q3 | $1.22M | Hold |
12,023
| – | – | ﹤0.01% | 991 |
|
|
2017
Q2 | $1.21M | Sell |
12,023
-27
| -0.2% | -$2.91K | ﹤0.01% | 978 |
|
|
2017
Q1 | $1.46M | Buy |
12,050
+28
| +0.2% | +$3.44K | 0.01% | 914 |
|
|
2016
Q4 | $1.34M | Buy |
12,022
+39
| +0.3% | +$4.69K | ﹤0.01% | 916 |
|
|
2016
Q3 | $1.59M | Buy |
11,983
+235
| +2% | +$22.5K | 0.01% | 817 |
|
|
2016
Q2 | $1.07M | Hold |
11,748
| – | – | ﹤0.01% | 976 |
|
|
2016
Q1 | $847K | Hold |
11,748
| – | – | ﹤0.01% | 1060 |
|
|
2015
Q4 | $816K | Sell |
11,748
-9
| -0.1% | -$733 | ﹤0.01% | 1074 |
|
|
2015
Q3 | $1.07M | Buy |
11,757
+8,559
| +268% | +$952K | ﹤0.01% | 927 |
|
|
2015
Q2 | $393K | Hold |
3,198
| – | – | ﹤0.01% | 1459 |
|
|
2015
Q1 | $291K | Hold |
3,198
| – | – | ﹤0.01% | 1618 |
|
|
2014
Q4 | $216K | Buy |
3,198
+2,705
| +549% | +$198K | ﹤0.01% | 1730 |
|
|
2014
Q3 | $40K | Buy |
493
+100
| +25% | +$8.85K | ﹤0.01% | 2597 |
|
|
2014
Q2 | $42K | Hold |
393
| – | – | ﹤0.01% | 2571 |
|
|
2014
Q1 | $23K | Buy |
+393
| New | +$23.4K | ﹤0.01% | 2788 |
|
Other funds holding GWPH
US Bancorp's GWPH Position: Q2 2021 in Review
US Bancorp sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 780 shares — an estimated $169K sold.
US Bancorp first reported a position in GWPH in Q1 2014 and held it in 29 quarters. The position peaked at $2.04M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- US Bancorp reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- US Bancorp sold 780 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $169K.
- US Bancorp first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 29 quarters.
- US Bancorp's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.04M in Q2 2019.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on US Bancorp's 13F filing for Q2 2021, filed 5 Aug 2021.